PAX3 and alveolar rhabdomyosarcoma: But PAX3-FOXO1 is more common accounting for about 55% of ARMS cases than PAX7-FOXO1 with 22% of ARMS and is associated with worse prognosis and lower overall survival rate in this disease [7–9].